Evidence map›Paper›PMID 32020046›Full record

ArticleLeukemia2020

Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosis.

Ferran Nadeu, Romina Royo, Francesco Maura, Kevin J Dawson, Ana Dueso-Barroso, Marta Aymerich, Magda Pinyol, Sílvia Beà, Armando López-Guillermo, Julio Delgado and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ferran NadeuInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0003-2910-9440
Romina RoyoBarcelona Supercomputing Center (BSC), Barcelona, Spain.
Francesco MauraMyeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kevin J DawsonWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
Ana Dueso-BarrosoBarcelona Supercomputing Center (BSC), Barcelona, Spain.ORCID http://orcid.org/0000-0003-2000-9718
Marta AymerichInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Magda PinyolCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Sílvia BeàInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Armando López-GuillermoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Julio DelgadoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Xose S PuenteDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.ORCID http://orcid.org/0000-0001-9525-1483
Elías CampoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. ecampo@clinic.cat.ORCID http://orcid.org/0000-0001-9850-9793

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic HeterogeneityAgedAged, 80 and overBone MarrowCohort StudiesExome SequencingFemaleFollow-Up StudiesHumansLeukemia, Lymphocytic, Chronic, B-CellLeukocytes, MononuclearLymph NodesMaleMiddle AgedPrognosisSpatial Analysis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.